Statement Of Cash Flows [Abstract]

Amplitude Surgical - Filing #2387647

Concept 2023-07-01 to
2024-06-30
2023-07-01 to
2024-06-30
2023-07-01 to
2024-06-30
As at
2024-06-30
As at
2023-06-30
2022-07-01 to
2023-06-30
2022-07-01 to
2023-06-30
2022-07-01 to
2023-06-30
2022-07-01 to
2023-06-30
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Profit (loss)
1 528 EUR
1 528 EUR
1 528 EUR
39 246 EUR
38 528 EUR
718,000 EUR
39 246 EUR
Adjustments to reconcile profit (loss) [abstract]
Adjustments for income tax expense
92,000 EUR
769,000 EUR
Adjustments for decrease (increase) in inventories
5 428 EUR
3 695 EUR
Adjustments for share-based payments
- EUR
- EUR
Adjustments for losses (gains) on disposal of non-current assets
119,000 EUR
51 359 EUR
Income taxes paid (refund), classified as operating activities
1 050 EUR
943,000 EUR
Cash flows from (used in) operating activities
4 043 EUR
8 096 EUR
Cash flows from (used in) investing activities [abstract]
Purchase of property, plant and equipment, classified as investing activities
10 382 EUR
11 175 EUR
Purchase of intangible assets, classified as investing activities
8 553 EUR
8 219 EUR
Cash flows from (used in) investing activities
14 422 EUR
45 544 EUR
Cash flows from (used in) financing activities [abstract]
Proceeds from borrowings, classified as financing activities
9 370 EUR
11 917 EUR
Repayments of borrowings, classified as financing activities
9 917 EUR
48 821 EUR
Cash flows from (used in) financing activities
2 483 EUR
37 434 EUR
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
7 896 EUR
16 205 EUR
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
194,000 EUR
38,000 EUR
Cash and cash equivalents
29 101 EUR
37 212 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.